JP2023544716A5 - - Google Patents
Info
- Publication number
- JP2023544716A5 JP2023544716A5 JP2023519608A JP2023519608A JP2023544716A5 JP 2023544716 A5 JP2023544716 A5 JP 2023544716A5 JP 2023519608 A JP2023519608 A JP 2023519608A JP 2023519608 A JP2023519608 A JP 2023519608A JP 2023544716 A5 JP2023544716 A5 JP 2023544716A5
- Authority
- JP
- Japan
- Prior art keywords
- methylpyridine
- pyrazole
- acetamide
- quinoline
- benzoate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20382861.1A EP3978487A1 (en) | 2020-09-30 | 2020-09-30 | 2-(3-pyridin-2-yl-4-quinolin-4-yl-pyrazol-1-yl)-acetamide derivatives as inhibitors of transforming growth factor-beta receptor i/alk5 |
| EP20382861.1 | 2020-09-30 | ||
| PCT/EP2021/076730 WO2022069509A1 (en) | 2020-09-30 | 2021-09-29 | 2-(3-pyridin-2-yl-4-quinolin-4-yl-pyrazol-1-yl)-acetamide derivatives as inhibitors of transforming growth factor-beta receptor i/alk5 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023544716A JP2023544716A (ja) | 2023-10-25 |
| JP2023544716A5 true JP2023544716A5 (cg-RX-API-DMAC7.html) | 2024-10-08 |
| JP7752684B2 JP7752684B2 (ja) | 2025-10-10 |
Family
ID=72744716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023519608A Active JP7752684B2 (ja) | 2020-09-30 | 2021-09-29 | トランスフォーミング増殖因子-β受容体I/ALK5の阻害剤としての2-(3-ピリジン-2-イル-4-キノリン-4-イル-ピラゾール-1-イル)-アセタミド誘導体 |
Country Status (20)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112022010251A2 (pt) | 2019-11-28 | 2022-09-06 | Origo Biopharma S L | Derivados de benzilamida como inibidores do receptor i/alk5 do fator de transformação de crescimento beta |
| WO2026017797A1 (en) | 2024-07-17 | 2026-01-22 | Agomab Spain S.L.U. | Crystalline forms |
| WO2026082960A1 (en) | 2024-10-18 | 2026-04-23 | Agomab Therapeutics Nv | 1,5-naphtyridine and quinoline based inhibitors of alk5 |
| WO2026082968A1 (en) | 2024-10-18 | 2026-04-23 | Agomab Therapeutics Nv | Novel compounds |
| CN121554469B (zh) * | 2026-01-23 | 2026-04-17 | 四川大学华西医院 | 一种alk5 protac化合物及其应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ501112A (en) * | 1997-05-22 | 2002-10-25 | G | Substituted pyrazoles as p38 kinase inhibitors |
| US6514977B1 (en) * | 1997-05-22 | 2003-02-04 | G.D. Searle & Company | Substituted pyrazoles as p38 kinase inhibitors |
| ATE291020T1 (de) * | 2001-02-02 | 2005-04-15 | Smithkline Beecham Corp | Pyrazolderivate gegen tgf überexprimierung |
| WO2004026306A2 (en) | 2002-09-18 | 2004-04-01 | Pfizer Products Inc. | Pyrazole derivatives as transforming growth factor (tgf) inhibitors |
| WO2004026302A1 (en) | 2002-09-19 | 2004-04-01 | Eli Lilly And Company | Methods of inhibiting tgf beta with substituted pyrazoles |
| CL2004000234A1 (es) | 2003-02-12 | 2005-04-15 | Biogen Idec Inc | Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid |
| JP2009500419A (ja) * | 2005-07-05 | 2009-01-08 | アリックス セラピューティクス、インコーポレイテッド | 立体異性体のピリジル及びピリドニル化合物並びに消化管障害及び中枢神経系障害の治療方法 |
| CN102056907B (zh) * | 2008-04-04 | 2014-12-31 | 武田药品工业株式会社 | 杂环衍生物及其用途 |
| US8937150B2 (en) | 2009-06-11 | 2015-01-20 | Abbvie Inc. | Anti-viral compounds |
| WO2011076725A1 (en) | 2009-12-21 | 2011-06-30 | Bayer Cropscience Ag | Thienylpyri (mi) dinylazole and their use for controlling phytopathogenic fungi |
| RU2612958C2 (ru) * | 2011-07-13 | 2017-03-14 | Ск Кемикалз Ко., Лтд. | 2-пиридилзамещенные имидазолы в качестве ингибиторов alk5 и/или alk4 |
| IN2014CN02805A (cg-RX-API-DMAC7.html) | 2011-10-14 | 2015-07-03 | Bristol Myers Squibb Co | |
| WO2016172631A2 (en) | 2015-04-24 | 2016-10-27 | President And Fellows Of Harvard College | Substrate selective inhibitors of insulin-degrading enzyme (ide) and uses thereof |
| JP2021518855A (ja) | 2018-03-02 | 2021-08-05 | ユニヴェルシテ ド ローザンヌ | Wntシグナル伝達経路阻害剤としてのピラゾール誘導体 |
| US11945803B2 (en) | 2018-08-07 | 2024-04-02 | Tosk, Inc. | Modulators of RAS GTPase |
| CN110433164A (zh) | 2019-08-15 | 2019-11-12 | 南开大学 | TGF-beta受体分子抑制剂在治疗小鼠动物模型中急性髓系白血病的应用 |
| BR112022010251A2 (pt) | 2019-11-28 | 2022-09-06 | Origo Biopharma S L | Derivados de benzilamida como inibidores do receptor i/alk5 do fator de transformação de crescimento beta |
-
2020
- 2020-09-30 EP EP20382861.1A patent/EP3978487A1/en not_active Withdrawn
-
2021
- 2021-09-17 AR ARP210102591A patent/AR123543A1/es unknown
- 2021-09-29 IL IL301663A patent/IL301663B2/en unknown
- 2021-09-29 BR BR112023004612A patent/BR112023004612A2/pt unknown
- 2021-09-29 AU AU2021353965A patent/AU2021353965A1/en active Pending
- 2021-09-29 JP JP2023519608A patent/JP7752684B2/ja active Active
- 2021-09-29 MX MX2023002900A patent/MX2023002900A/es unknown
- 2021-09-29 RS RS20260828A patent/RS68301B1/en unknown
- 2021-09-29 US US18/246,903 patent/US12577230B2/en active Active
- 2021-09-29 KR KR1020237008242A patent/KR20230079027A/ko active Pending
- 2021-09-29 LT LTEPPCT/EP2021/076730T patent/LT4222149T/lt unknown
- 2021-09-29 PH PH1/2023/550777A patent/PH12023550777A1/en unknown
- 2021-09-29 CN CN202180066883.4A patent/CN116323601B/zh active Active
- 2021-09-29 EP EP26171404.2A patent/EP4781988A2/en active Pending
- 2021-09-29 WO PCT/EP2021/076730 patent/WO2022069509A1/en not_active Ceased
- 2021-09-29 EP EP21786169.9A patent/EP4222149B1/en active Active
- 2021-09-29 FI FIEP21786169.9T patent/FI4222149T3/fi active
- 2021-09-29 PT PT217861699T patent/PT4222149T/pt unknown
- 2021-09-29 ES ES21786169T patent/ES3029607T3/es active Active
- 2021-09-29 CA CA3196108A patent/CA3196108A1/en active Pending
- 2021-09-29 DK DK21786169.9T patent/DK4222149T3/da active
-
2023
- 2023-02-23 ZA ZA2023/02393A patent/ZA202302393B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA3093851A1 (en) | Substituted 1,1'-biphenyl compounds, analogues thereof, and methods using same | |
| RU2004117887A (ru) | Ариланилиновые агонисты бета2 адренергических рецепторов | |
| JP2017502033A5 (cg-RX-API-DMAC7.html) | ||
| RU2012116877A (ru) | Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы | |
| JP2022505841A5 (cg-RX-API-DMAC7.html) | ||
| JP2005538099A5 (cg-RX-API-DMAC7.html) | ||
| RU2011121567A (ru) | Изоиндолиновые соединения для применения при лечении рака | |
| JP2021535112A5 (cg-RX-API-DMAC7.html) | ||
| CN107325048A (zh) | 使用c‑Met调节剂的方法 | |
| ES3029607T1 (en) | 2-(3-pyridin-2-yl-4-quinolin-4-yl-pyrazol-1-yl)-acetamide derivatives as inhibitors of transforming growth factor-beta receptor i/alk5 | |
| RU2005137403A (ru) | Новые замещенные 3-сера-индолы | |
| RU2009148673A (ru) | Производные пиразинона и их применение для лечения легочных заболеваний | |
| JP2008509187A5 (cg-RX-API-DMAC7.html) | ||
| IL205501A (en) | Preparation of preparations for the treatment of arthritis | |
| RU2014115290A (ru) | Производные 1-фенил 2-пиридинилалкиловых спиртов в качестве ингибиторов | |
| JP2020527173A5 (cg-RX-API-DMAC7.html) | ||
| JP2007505931A5 (cg-RX-API-DMAC7.html) | ||
| TW200304824A (en) | Nicotinamide derivatives useful as PDE4 inhibitors | |
| JP2024510939A5 (cg-RX-API-DMAC7.html) | ||
| JP2008517923A5 (cg-RX-API-DMAC7.html) | ||
| JP2013542267A5 (cg-RX-API-DMAC7.html) | ||
| PT1948176E (pt) | Diaril ureias para tratar a hipertensão pulmonar | |
| WO2021170811A1 (en) | Method of treating eye disease using trpv4 antagonists | |
| RU2008112181A (ru) | Применение конденсированных производных имидазола для лечения заболеваний, опосредованных рецептором ccr3 | |
| HUE027375T2 (en) | Phenyl guanidine derivatives |